{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:37:20Z","timestamp":1787020640307,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Key Research and Development Plan","award":["2016YFC0903500"],"award-info":[{"award-number":["2016YFC0903500"]}]},{"name":"Major program of Health Medical Collaborate Innovation of Guangzhou","award":["201604020013"],"award-info":[{"award-number":["201604020013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dyslipidemia often concurs with hyperuricemia. Our study was to discover different lipid levels of gout and asymptomatic hyperuricemia and the predictors of sUA (serum uric acid) levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A cross-sectional study was performed to collect demographic, clinical variables, comorbidities and laboratory testing in patients with gout and asymptomatic hyperuricemia. Group comparison was performed with Student\u2019s\n                      <jats:italic>t<\/jats:italic>\n                      -test or Mann Whitney U test for continuous variables and chi-squared tests for categorical variables (Fisher\u2019s exact test where appropriate) and to screen potential risk factors. Correlation of sUA levels with demographic and biochemical variables were performed by using correlation analysis. The variable with s\n                      <jats:italic>p<\/jats:italic>\n                      -value less than 0.20 during the group comparison or clinical relevance was introduced into the stepwise multiple regression model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Six hundred fifty-three patients with gout and 63 patients with asymptomatic hyperuricemia (&gt;\u2009420\u2009\u03bcmol\/L in male and\u2009&gt;\u2009360\u2009\u03bcmol\/L in female) were enrolled, including 553 (84.7%) males. The mean age was 47.8\u2009\u00b1\u200916.0\u2009years old. Elevated total cholesterol (TC) was observed in 173 (26.5%) cases with gout. Increased triglycerides (TG) and low-density lipoprotein (LDL-C) levels were observed in 242 (37.1%) cases and 270 (41.3%) cases with gout, individually. In contrast, elevated TC, TG and LDL-C levels were observed in 10 (15.9%) cases, 30 (47.6%) cases and 22 (34.9%) cases with hyperuricemia, individually. Significant differences were found in age, serum creatine, TC and erythrocyte sedimentation rate (ESR) between gout and asymptomatic hyperuricemia groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). In patients with asymptomatic hyperuricemia, 12 (19.0%) patients had hypertension and 5 (7.9%) suffered from coronary heart diseases. Male (B\u2009=\u2009-112.7,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), high-density lipoprotein (HDL-C) (B\u2009=\u2009-60.797,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.013), body mass index (BMI) (B\u2009=\u20095.168,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.024), age (B\u2009=\u2009-3.475,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.006), age of hyperuricemia onset (B\u2009=\u20092.683,\n                      <jats:italic>p\u2009=<\/jats:italic>\n                      \u00a00.032), and serum creatine (B\u2009=\u20090.534,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) were predictors of sUA levels in gout patients (adjusted R\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200928.7%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Dyslipidemia is more commonly seen in patients with gout, compared to asymptomatic hyperuricemia. HDL-C is a protective predictor of sUA levels in gout.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12944-020-1197-y","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T05:03:14Z","timestamp":1583211794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: a cross-sectional study"],"prefix":"10.1186","volume":"19","author":[{"given":"Jing","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yefei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayong","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiujing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieruo","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,3]]},"reference":[{"key":"1197_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1471-2474-12-103","volume":"12","author":"P Primatesta","year":"2011","unstructured":"Primatesta P, Plana E, Rothenbacher D. Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population. BMC Musculoskelet Disord. 2011;12:103.","journal-title":"BMC Musculoskelet Disord"},{"key":"1197_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12944-017-0531-5","volume":"16","author":"X Zheng","year":"2017","unstructured":"Zheng X, Gong L, Luo R, et al. Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults. Lipids Health Dis. 2017;16:202.","journal-title":"Lipids Health Dis"},{"key":"1197_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2013.08.023","volume":"231","author":"G Zhao","year":"2013","unstructured":"Zhao G, Huang L, Song M, Song Y. Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies. ATHEROSCLEROSIS. 2013;231:61\u20138.","journal-title":"ATHEROSCLEROSIS."},{"key":"1197_CR4","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1161\/hy1101.092839","volume":"38","author":"M Mazzali","year":"2001","unstructured":"Mazzali M, Hughes J, Kim YG, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. HYPERTENSION. 2001;38:1101\u20136.","journal-title":"HYPERTENSION."},{"key":"1197_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12872-019-1026-2","volume":"19","author":"N Ali","year":"2019","unstructured":"Ali N, Rahman S, Islam S, et al. The relationship between serum uric acid and lipid profile in Bangladeshi adults. BMC Cardiovasc Disord. 2019;19:42.","journal-title":"BMC Cardiovasc Disord"},{"key":"1197_CR6","first-page":"8","volume":"65","author":"WX Yang","year":"2019","unstructured":"Yang WX, Ma Y, Hou YL, et al. Prevalence of Hyperuricemia and its Correlation with Serum Lipids and Blood Glucose in Physical Examination Population in 2015\u20132018: a Retrospective Study. Clin Lab. 2019;65:8.","journal-title":"Clin Lab"},{"key":"1197_CR7","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.amjcard.2015.07.059","volume":"116","author":"Y Saito","year":"2015","unstructured":"Saito Y, Nakayama T, Sugimoto K, et al. Relation of lipid content of coronary plaque to level of serum uric acid. Am J Cardiol. 2015;116:1346\u201350.","journal-title":"Am J Cardiol"},{"key":"1197_CR8","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/art.39254","volume":"67","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TL, Dalbeth N, et al. 2015 gout classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative. ARTHRITIS RHEUMATOL. 2015;67:2557\u201368.","journal-title":"ARTHRITIS RHEUMATOL"},{"key":"1197_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.biochi.2015.06.025","volume":"116","author":"WG Lima","year":"2015","unstructured":"Lima WG, Martins-Santos ME, Chaves VE. Uric acid as a modulator of glucose and lipid metabolism. BIOCHIMIE. 2015;116:17\u201323.","journal-title":"BIOCHIMIE"},{"issue":"6","key":"1197_CR10","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3390\/jcm8060837","volume":"8","author":"IY Kim","year":"2019","unstructured":"Kim IY, Han KD, Kim DH, et al. Women with metabolic syndrome and general obesity are at a higher risk for significant Hyperuricemia compared to men. J Clin Med. 2019;8(6):837.","journal-title":"J Clin Med"},{"issue":"1","key":"1197_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/ijerph14010067","volume":"14","author":"J Cao","year":"2017","unstructured":"Cao J, Wang C, Zhang G, et al. Incidence and simple prediction model of Hyperuricemia for urban Han Chinese adults: a prospective cohort study. Int J Environ Res Public Health. 2017;14(1):67.","journal-title":"Int J Environ Res Public Health"},{"key":"1197_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2174\/1573397114666180705095625","volume":"15","author":"QB Zhang","year":"2019","unstructured":"Zhang QB, Zhu D, Wen Z, et al. High levels of serum uric acid, Cystain C and lipids concentration and their clinical significance in primary gouty Arthritis patients. Curr Rheumatol Rev. 2019;15:141\u20135.","journal-title":"Curr Rheumatol Rev"},{"key":"1197_CR13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.archger.2016.02.002","volume":"64","author":"S Guan","year":"2016","unstructured":"Guan S, Tang Z, Fang X, et al. Prevalence of hyperuricemia among Beijing post-menopausal women in 10 years. Arch Gerontol Geriatr. 2016;64:162\u20136.","journal-title":"Arch Gerontol Geriatr"},{"key":"1197_CR14","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.2337\/db10-0916","volume":"60","author":"W Baldwin","year":"2011","unstructured":"Baldwin W, McRae S, Marek G, et al. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. DIABETES. 2011;60:1258\u201369.","journal-title":"DIABETES"},{"key":"1197_CR15","first-page":"S42","volume":"153","author":"JI Leon-Pedroza","year":"2017","unstructured":"Leon-Pedroza JI, Escobedo G, Gonzalez-Chavez A. Relationship of hyperuricemia with low density lipoprotein , liver function tests and markers of systemic inflammation in patients with morbid obesity. Gac Med Mex. 2017;153:S42\u201350.","journal-title":"Gac Med Mex"},{"key":"1197_CR16","first-page":"F727","volume":"304","author":"E Tapia","year":"2013","unstructured":"Tapia E, Cristobal M, Garcia-Arroyo FE, et al. Synergistic effect of uricase blockade plus physiological amounts of fructose-glucose on glomerular hypertension and oxidative stress in rats. Am J Phys Renal Phys. 2013;304:F727\u201336.","journal-title":"Am J Phys Renal Phys"},{"key":"1197_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.numecd.2007.02.011","volume":"17","author":"P Strazzullo","year":"2007","unstructured":"Strazzullo P, Puig JG. Uric acid and oxidative stress: relative impact on cardiovascular risk? Nutr Metab Cardiovasc Dis. 2007;17:409\u201314.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1197_CR18","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.amjmed.2005.03.043","volume":"118","author":"JF Baker","year":"2005","unstructured":"Baker JF, Krishnan E, Chen L, et al. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med. 2005;118:816\u201326.","journal-title":"Am J Med"},{"key":"1197_CR19","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jacl.2013.08.001","volume":"7","author":"PP Toth","year":"2013","unstructured":"Toth PP, Barter PJ, Rosenson RS, et al. High-density lipoproteins: a consensus statement from the National Lipid Association. J CLIN LIPIDOL. 2013;7:484\u2013525.","journal-title":"J CLIN LIPIDOL"},{"key":"1197_CR20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.5114\/aoms.2016.60971","volume":"12","author":"M Rysz-Gorzynska","year":"2016","unstructured":"Rysz-Gorzynska M, Banach M. Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients. Arch Med Sci. 2016;12:844\u20139.","journal-title":"Arch Med Sci"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-020-1197-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-020-1197-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-020-1197-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T19:09:26Z","timestamp":1614712166000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-020-1197-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,3]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1197"],"URL":"https:\/\/doi.org\/10.1186\/s12944-020-1197-y","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,3]]},"assertion":[{"value":"6 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee of the Third Affiliated Hospital of Sun Yat-sen University [(2017) 02\u2013295-01] and conducted in compliance with Helsinki Declaration. All participants gave written informed consent of the study and possible publication before enrolment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication have be obtained from the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}